Phibro Animal Health (PAHC) Accounts Payables (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Accounts Payables of $129.6 million for Q1 2026, down 1.5% year-over-year from $131.6 million in Q1 2025, and down 2.74% quarter-over-quarter from $133.3 million in Q4 2025.
Phibro Animal Health (PAHC) Accounts Payables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Accounts Payables history runs 14 years deep, the most recent figure standing at $129.6 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 1.5% year-over-year to $129.6 million; the TTM figure through Mar 2026 stood at $129.6 million (down 1.5% YoY), while the FY2025 annual figure was $138.2 million, up 61.51% from the prior year.
- Accounts Payables for Q1 2026 stood at $129.6 million, down from $133.3 million in the prior quarter.
- The five-year high for Accounts Payables was $138.2 million in Q2 2025, with the low at $73.9 million in Q2 2023.
- The 5-year median for Accounts Payables is $88.4 million (2022), against an average of $99.1 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables dropped 22.74% in 2023, then surged 61.51% in 2025.
- Phibro Animal Health's Accounts Payables stood at $80.5 million in 2022, then rose by 7.36% to $86.4 million in 2023, then grew by 15.09% to $99.4 million in 2024, then soared by 34.04% to $133.3 million in 2025, then slipped by 2.74% to $129.6 million in 2026.
- Business Quant data shows PAHC's Accounts Payables at $129.6 million in Q1 2026, $133.3 million in Q4 2025, and $130.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 129.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.64 Mn |
| Dec 31, 2025 | 133.30 Mn |
| Sep 30, 2025 | 130.60 Mn |
| Jun 30, 2025 | 138.20 Mn |
| Mar 31, 2025 | 131.62 Mn |
| Dec 31, 2024 | 99.45 Mn |
| Sep 30, 2024 | 86.53 Mn |
| Jun 30, 2024 | 85.57 Mn |
| Mar 31, 2024 | 82.61 Mn |
| Dec 31, 2023 | 86.41 Mn |
| Sep 30, 2023 | 77.22 Mn |
| Jun 30, 2023 | 73.85 Mn |
| Mar 31, 2023 | 75.77 Mn |
| Dec 31, 2022 | 80.49 Mn |
| Sep 30, 2022 | 88.38 Mn |
| Jun 30, 2022 | 95.60 Mn |
| Mar 31, 2022 | 89.70 Mn |
| Dec 31, 2021 | 80.66 Mn |
| Sep 30, 2021 | 66.81 Mn |
| Jun 30, 2021 | 68.36 Mn |